Juvenescence Ltd is a life sciences and clinical-stage AI-enabled biotech company headquartered in Dublin, Ireland, dedicated to extending healthy lifespan through novel medicines.
Subscribe to see Juvenescence’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Juvenescence is a biotech company headquartered in Ireland. Its most recent funding round, Series B-1, raised $76M in May 2025. Xcout tracks 16 named people at Juvenescence, including Dr. Richard Marshall (Chief Executive Officer).
10 more named people on record for Juvenescence, with roles, board committees and tenure — see the full roster →
The 5 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B-1 | $76M | 1 named | |
| SEC Form D filing | $6.5M | — | |
| — | $100M | 1 named | |
| SEC Form D filing | $56.9M | — | |
| SEC Form D filing | $53.1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Juvenescence's closest competitors — see the full list of competitors and alternatives →
Integrated Biosciences is a physical AI and biotechnology research company developing multimodal biological approaches to engineer the future of aging.
Rejuvenate Biomed is an independent research and development biotechnology company spun out from the Janssen Pharmaceutical companies of Johnson & Johnson. Headquartered in Diepenbeek in the Flemish Region of Belgium, the company focuses on longevity research to keep people healthy longer. It also maintains a presence in Cambridge, Massachusetts.
Auransa is a clinical-stage, AI-native biopharmaceutical company headquartered in Palo Alto, California. It utilizes a proprietary artificial intelligence platform to mine massive human disease datasets for discovering novel therapeutics.
Ora Biomedical, Inc. is a longevity biotechnology pharmaceutical company headquartered in Tukwila, Washington, that identifies and develops longevity therapeutics and small molecules.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.